Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients
Status:
Completed
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
Prospective pilot study to determine if changing the phosphate binder to sucroferric
oxyhydroxide for for 6 months improves disordered mineral metabolism and nutrition status in
peritoneal dialysis patients.